Prempro is a combination hormone therapy pill used to treat moderate-to-severe menopause symptoms in women who still have a uterus. It combines two hormones, an estrogen and a progestin, into a single daily tablet. Its two main purposes are relieving hot flashes and other vasomotor symptoms of menopause, and preventing bone loss (osteoporosis) after menopause.
What Prempro Contains and Why
Prempro pairs conjugated estrogens with medroxyprogesterone acetate. The estrogen component does the heavy lifting for symptom relief. It replaces the estrogen your ovaries largely stop producing after menopause, which is what triggers hot flashes, night sweats, and vaginal dryness in the first place. Estrogen works by binding to receptors throughout your body and, among other things, dialing down the surge of reproductive hormones (LH and FSH) that spike after menopause.
The progestin component exists for one critical reason: protecting your uterus. Estrogen taken alone stimulates the uterine lining to grow, which over time raises the risk of endometrial cancer. The progestin in Prempro counteracts this by slowing cell growth in the uterine lining and reducing the number of estrogen receptors there. This is why Prempro is specifically prescribed for women who have not had a hysterectomy. If you’ve had your uterus removed, estrogen-only therapy is typically used instead.
Relieving Menopause Symptoms
The primary reason most women take Prempro is to manage the vasomotor symptoms of menopause: hot flashes, night sweats, and the sleep disruption that comes with them. These symptoms affect the majority of women going through menopause and can range from mildly annoying to genuinely disruptive. For moderate-to-severe cases, hormone therapy remains one of the most effective treatments available.
Prempro can also help with vulvar and vaginal changes that happen after menopause, including dryness, irritation, and discomfort during sex. These symptoms result from the same drop in estrogen that causes hot flashes. However, if vaginal symptoms are your only concern, localized treatments (vaginal creams or inserts) are generally preferred over a systemic pill like Prempro, since they deliver estrogen directly where it’s needed with less exposure to the rest of your body.
Preventing Postmenopausal Bone Loss
Prempro’s second approved use is preventing osteoporosis after menopause. Estrogen plays a major role in maintaining bone density, and its decline after menopause accelerates bone loss. In clinical trials, Prempro increased bone mineral density in the lower spine by 1.7 to 3.3 percent over about a year, depending on the dose. The placebo group, by comparison, lost an average of 2.5 percent of their spinal bone density over the same period. Prempro also improved bone density at the hip and throughout the body.
That said, Prempro is not the first choice solely for bone protection. Prescribing guidelines specify it should only be used for osteoporosis prevention in women who are already at significant risk of fractures and for whom other bone-specific medications aren’t appropriate. If you’re taking Prempro primarily for hot flashes and it happens to protect your bones too, that’s a welcome bonus, but the risks of long-term use make it a less straightforward pick for bone health alone.
What Prempro Is Not For
Prempro should not be used to prevent heart disease or dementia. This distinction matters because for decades, hormone therapy was widely believed to protect the heart. The Women’s Health Initiative (WHI), a large study of postmenopausal women aged 50 to 79, changed that thinking. Over 5.6 years of follow-up, women taking the estrogen-plus-progestin combination had higher rates of blood clots, stroke, and heart attack compared to women taking a placebo.
A related memory study from the WHI found that women 65 and older taking the same combination had a higher risk of developing probable dementia over four years. Whether this applies to younger postmenopausal women is unknown, but the finding was significant enough to be included in the drug’s safety warnings.
Serious Risks to Know About
Prempro has historically carried some of the strongest safety warnings the FDA issues. The WHI trial identified increased risks of blood clots (both deep vein thrombosis and pulmonary embolism), stroke, heart attack, and invasive breast cancer in women using estrogen-plus-progestin therapy. These findings led to boxed warnings on the product label for cardiovascular disorders, breast cancer, and probable dementia.
In 2025, the FDA announced it was initiating the removal of the broad boxed warnings related to cardiovascular disease, breast cancer, and probable dementia from hormone therapy products, calling the original warning language misleading. The agency is working with manufacturers to update labeling. However, the boxed warning regarding endometrial cancer risk with estrogen-alone products is being retained. This regulatory shift reflects an evolving understanding that the risks identified in the WHI may not apply equally to all women, particularly younger women closer to the onset of menopause.
None of this means the risks have disappeared. The underlying study data hasn’t changed, and the decision to use Prempro still involves weighing symptom relief against potential harms. The general guidance from the American College of Obstetricians and Gynecologists is to use the lowest effective dose for the shortest time needed. About half of women who stop hormone therapy, regardless of how long they’ve been on it, experience a return of vasomotor symptoms, which makes the decision of when to stop a highly individual one.
Common Side Effects
Beyond the serious risks, Prempro can cause more everyday side effects. The most frequently reported ones in clinical trials include headaches, breast pain or tenderness, irregular vaginal bleeding or spotting (especially in the first few months), abdominal pain, and mood changes. Bloating, nausea, and back pain are also common. Many of these side effects ease after the first few months as your body adjusts.
Irregular bleeding is particularly common early on. Because Prempro delivers both hormones continuously every day, it’s designed to eventually stop monthly periods altogether. But during the transition, breakthrough bleeding is normal. If bleeding persists or starts after you’ve gone months without it, that warrants a conversation with your provider, since unexpected uterine bleeding always needs evaluation.
How Treatment Typically Works
Prempro is taken as one tablet daily, with or without food. It comes in several dose combinations, with the estrogen and progestin components adjusted together. Your provider will typically start you on the lowest dose likely to control your symptoms and adjust from there.
There’s no fixed rule for how long you should take it. The prevailing guidance is to reassess periodically, weighing whether your symptoms are still severe enough to justify continued use. Some women use it for a year or two, others for longer. The choice to continue is based on your individual symptoms, risk factors, and how you respond to the medication. If and when you stop, tapering gradually rather than quitting abruptly may help reduce the chance of symptoms bouncing back, though recurrence is common either way.